RIGL icon

Rigel Pharmaceuticals
RIGL

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$45
59% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Joseph Pantginis
67% 1-yr RIGL win rate
8 Oct ‘25 10 days ago
Cantor Fitzgerald
Cantor Fitzgerald
Kristen Kluska
6 Aug ‘25 2 months ago